Varex Imaging (VREX) Stock
X-ray component specialist for medical and industrial markets. Here's the price, business snapshot, and what's worth knowing about Varex Imaging in September 2026.
Varex Imaging Corporation (VREX) designs and supplies X‑ray imaging components and subsystems used by medical, veterinary and industrial equipment makers. The company's products include X‑ray tubes, digital detectors and power electronics that feed into diagnostic imaging systems and non‑destructive testing machines. With a market capitalisation around $483.48M, Varex is positioned as a specialist supplier rather than an OEM, so revenue is linked to capital equipment cycles, hospital and clinical investment and industrial inspection demand. Investors should note drivers such as ageing populations, diagnostic upgrades and industrial automation, alongside risks including cyclical capital spending, pricing pressure from larger suppliers and supply‑chain sensitivity. The stock can be more volatile than large-cap healthcare names; values may rise or fall and past performance is not indicative of future returns. This summary is educational only and not personal financial advice — consider your risk tolerance, investment horizon and seek independent advice where appropriate.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Varex Imaging's stock, with a target price of $21.98, indicating future potential.
Financial Health
Varex Imaging is performing well with solid revenue and cash generation, reflecting a healthy business.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Medical imaging demand
Ageing populations and diagnostic upgrades can drive steady demand for imaging components, though capital spending cycles can introduce volatility.
Component supplier role
Longstanding OEM relationships and specialised technology are strengths, but margins and order timing can vary with competitive and supply pressures.
Industrial and global reach
Sales span medical and industrial markets across regions, offering diversification, though global exposure brings currency and regulatory considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
